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Abstract: This paper addresses model identification of continuous-discrete nonlinear models for
people with type 1 diabetes using sampled data from a continuous glucose monitor (CGM). We
compare five identification techniques: least squares, weighted least squares, Huber regression,
maximum likelihood with extended Kalman filter and maximum likelihood with unscented
Kalman filter. We perform the identification on a 24-hour simulation of a stochastic differential
equation (SDE) version of the Medtronic Virtual Patient (MVP) model including process and
output noise. We compare the fits with the actual CGM signal, as well as the short- and
long-term predictions for each identified model. The numerical results show that the maximum
likelihood-based identification techniques offer the best performance in terms of fitting and
prediction. Moreover, they have other advantages compared to ODE-based modeling, such as
parameter tracking, population modeling and handling of outliers.
Keywords: Type 1 diabetes, parameter identification, continuous glucose monitoring, least
squares, Huber regression, maximum likelihood
1. INTRODUCTION
The artificial pancreas (AP), i.e. automated or semi-
automated control of blood glucose, has the potential to
improve the regulation of blood glucose levels in people
with type 1 diabetes (T1D) compared to the current in-
sulin therapy. According to Meece (2015), it is estimated
to be commercially available within 5 to 7 years for the
first versions. Although this estimate may be optimistic,
it shows that the research on the AP is progressing rapidly
and that the goal of having a commercially available AP
is becoming closer. In its single-hormone version, current
prototypes of the AP consist of a continuous glucose mon-
itor (CGM) for glucose sensing, a control algorithm imple-
mented on a smartphone and a continuous subcutaneous
insulin infusion (CSII) pump. Fig. 1 illustrates the AP.
Meals represent a major challenge for the control algo-
rithm due to the high nonlinearity of the insulin-glucose
dynamics. For a normal or large meal size, algorithms
based on linear model predictive control (MPC) are in-
adequate to handle meals, as they tend to underestimate
the action of insulin on blood glucose, usually resulting in
hypoglycemia, as shown in Boiroux et al. (2010c). To han-
dle meals properly, some of the control algorithms based on
MPC have attempted to separate the bolus calculator from
the basal insulin administration, for instance Marchetti
et al. (2008); Ba´tora et al. (2015). Control algorithms
? This work has been funded by the Danish Diabetes Academy
supported by the Novo Nordisk Foundation.
Fig. 1. The single-hormone artificial pancreas.
based on nonlinear MPC (NMPC) can be used to compute
the optimal bolus delivery and to dose the basal and bolus
insulin in a safe way, provided that they can be identified.
Control algorithms based on NMPC have been tested on
real patients (Hovorka et al. (2004); Schaller et al. (2006))
and on virtual patients (Magni et al. (2008); Boiroux et al.
(2010b)).
Another requirement for control algorithms based on MPC
is to determine a suitable and adaptive control-relevant
prediction model, as in Jørgensen and Jørgensen (2007b);
Boiroux et al. (2015). For patients with T1D, numerous
physiological models exist. These models describe the sub-
cutaneous insulin absorption, the glucose-insulin dynamics
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and the carbohydrates (CHO) absorption. They usually
consist either of a system of ordinary differential equations
(ODEs) (e.g. the models developed by Hovorka et al.
(2004); Kanderian et al. (2009); Dalla Man et al. (2014)),
or a system of stochastic differential equations (SDEs)
(Duun-Henriksen et al. (2013)). The former uses in most
cases least squares fitting, while the latter uses maximum
likelihood for parameter identification. In both cases, the
identification requires to have access to parameters that
are inaccessible in everyday life, for example plasma glu-
cose and plasma insulin data. In practice, patients with
T1D must only rely on data from a CGM to obtain
frequent (usually, every 5 minutes) glucose measurements
usable for model identification and glucose regulation.
The key contribution of the present paper is to evaluate
and discuss model identification procedures based on CGM
data that can be used for simulation and/or NMPC. To
our knowledge, this problem has not been addressed so
far. Here, we compare least squares, Huber regression
and maximum likelihood fitting using continuous-discrete
filtering for state estimation. We design these identification
techniques in such a way that they could be part of
a closed-loop control algorithm. We generate a 24-hour
simulated dataset including bolused meals and simulate a
virtual patient using a modified version of the Medtronic
Virtual Patient (MVP) model, such that we can compare
the identified parameter values with the actual ones. This
version of the MVP model simulates random metabolic
variations and comprises a noise-corrupted CGM model.
We also discuss the potential and the challenges of these
identification techniques regarding their applicability to
nonlinear control.
This paper is structured as follows. Section 2 gives a
stochastic formulation of a physiological model for patients
with T1D. Section 3 shows the methods used for parameter
estimation. Section 4 shows the performance of the model
identification techniques and discusses the potential ap-
plication to closed-loop control. Section 5 summarizes the
main contributions of this paper.
2. PHYSIOLOGICAL MODEL
In this paper, we use model similar to the Medtronic
Virtual Patient (MVP) model presented in Kanderian
et al. (2009). The initial MVP model consists of a set
of nonlinear ODEs. It has been designed to be easier to
identify.
We augment this model with the CGM noise model
developed by Facchinetti et al. (2014), and we reformulate
this model as a stochastic differential equation-grey box
(SDE-GB) model as in Duun-Henriksen et al. (2013). A
SDE-GB model is a model in the form
dx(t) = f(t, x(t), u(t), θ)dt+ σdω(t) (1a)
yk = h(tk, x(tk)) + vk (1b)
in which x(t) is the state vector. u(t) is the input vector.
Here, we assume a zero-order hold parametrization, i.e.
u(t) = uk for tk ≤ t < tk+1. θ represents the model pa-
rameters we want to identify. {dω(t), t ≥ 0} is a standard
Wiener process with covariance Idt. σdω(t) models the
unknown disturbances to the system, e.g. changes in the
metabolism, cyclic hormone variations etc. For simplicity,
we assume in this paper that the matrix σ is diagonal
and time-invariant. The measurement noise vk is normally
distributed, vk ∼ Niid(0, R).
The following subsections state the SDE-GB model used
for simulation and parameter identification. The numerical
values of the model parameters are summarized in Table
1.
2.1 Insulin Absorption Subsystem
The insulin absorption subsystem is given by the following
two-compartment model
dISC =
(
u(t)
CIτ1
− ISC(t)
τ1
)
dt+ σ1dω1 (2a)
dIP =
(
ISC(t)− IP (t)
τ2
)
dt+ σ2dω2 (2b)
where ISC(t) [mU/L/min] is the subcutaneous insulin
concentration, and IP (t) [mU/L] is the plasma insulin
concentration. u(t) [mU/min] is the insulin infusion rate,
CI [L/min] is the clearance rate. τ1 and τ2 [min] are the
insulin absorption time constants. It must be pointed out
that these time constants are interchangeable.
2.2 Insulin-Glucose Dynamics
The effect of insulin on blood glucose is described by the
following SDEs
dIEFF = (−p2IEFF (t) + p2SIIP (t)) dt+ σ3dω3 (2c)
dG = (−(IEFF (t) +GEZI)G(t) + EGP+
RA(t))dt+ σ4dω4 (2d)
IEFF (t) [min
−1] is the effect of insulin. p2 [min−1]
is a parameter and SI [mL/mU] reflects the insulin
sensitivity. The glucose concentration G(t) [mg/dL] is
also affected by the glucose elimination at zero insulin
rate (GEZI) [min−1], the endogenous glucose production
(EGP ) [mg/dL/min] and the glucose rate of appearance
RA(t) [mg/dL/min].
The insulin effect and the glucose dynamics (2c)-(2d) are
similar to the one developed by Bergman et al. (1981). This
formulation allows for an easier parameter identification
compared to other physiological models.
2.3 CHO Absorption Model
We use the two-compartment model introduced by Hov-
orka et al. Hovorka et al. (2004) to describe the CHO
absorption and conversion to glucose. The model describes
the effect of orally ingested carbohydrates on the rate of
appearance of glucose RA(t) [mg/dL/min] in the blood
stream. The model is
dD1 =
(
d(t)− D1(t)
τG
)
dt+ σ5dω5 (2e)
dD2 =
(
D1(t)−D2(t)
τG
)
dt+ σ6dω6 (2f)
RA(t) =
D2(t)
τGVG
(2g)
d(t) [mg/min] is the meal intake. τG [min] is the meal
absorption time constant and VG [dL
−1] is the glucose
distribution volume.
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2.4 CGM Model
We use here the CGM model from Facchinetti et al. (2014).
This model represents the glucose transport from plasma
to interstitial tissues and the sensor noise. The glucose
transport is given as
dGSC =
1
τG,SC
(G(t)−GSC(t)) dt+ σ7dω7 (2h)
where the time constant τG,SC is 6.7 min. The sensor
noise is represented by the sum of the two following
autoregressive processes
cck = 1.23cck−1 − 0.3995cck−2 + wcc,k (3a)
vˆk = 1.013vˆk−1 − 0.2135vˆk−2 + wk (3b)
in which wcc,k ∼ N(0,11.3 mg2/dL2) and wk ∼ N(0,14.45
mg2/dL2). Thus, the discrete noise-corrupted value re-
turned by the glucose sensor and used in (1b) at the time
tk is
yk = GSC(tk) + cck + vˆk (4)
3. PARAMETER ESTIMATION
In this section, we introduce the model identification tech-
niques used in this paper. In total, we implemented five
different techniques: the least squares, the weighted least
squares, the Huber regression, the maximum likelihood us-
ing an extended Kalman filter and the maximum likelihood
using an unscented Kalman filter. All the optimization
computations have been performed in MATLAB R2014a
(Mathworks, Natick, Massachusetts).
3.1 Least Squares Estimation
In the least squares estimation, the aim is to find the set
of parameters θˆ minimizing the unweighted squares of the
residuals, i.e.
θˆ = argmin
θ
N∑
i=1
‖yi(θ)− y¯i‖22 (5)
in which yi(θ) is the estimated output (here, the BG level)
and y¯i is the measured output. A more general formulation
is the weighted least squares given by
θˆ = argmin
θ
N∑
i=1
‖yi(θ)− y¯i‖2Wi (6)
A popular choice of weight is Wi = diag(1/y¯i)
2. This
choice gives more weight to smaller observations (here, to
low BG levels), and ensures that the term in the objective
function is unitless.
3.2 Huber Regression
An alternative to the least square fitting is the Huber
regression (Finan et al. (2010); Huber (2011)). The un-
derlying idea behind the Huber regression is to decrease
the influence of outliers on the identification by decreasing
the penalty for high residual values. In the case of model
identification based on CGM data, outliers may occur, if
for instance the patient lies on the sensor. The objective
function is to find the set of parameters θˆ satisfying
θˆ = argmin
θ
N∑
i=1
ρ(ei) (7)
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Fig. 2. Penalty function for the least squares and the Huber
norm regression for γ = 1.
in which the cost ρ(ei) is defined as
ρ(ei) =
{
e2i |ei| ≤ γ
2γ|ei| − e2i |ei| > γ
(8)
where ei = yi(θ)−y¯i is the residual. It must also be pointed
out that the function ρ is continuously differentiable. Fig.
2 depicts the penalty function for the least squares and
the Huber norm regression.
3.3 Maximum Likelihood
For a Gaussian distribution and a set of observations
given a set of model parameters YN |θ, the -log-likelihood
function is
L(θ) = − ln (p(YN |θ)) (9)
=
(N + 1)ny
2
ln(2pi)+
1
2
N∑
k=0
ln [det(Re,k)] + e
′
k[Re,k]
−1ek (10)
where Re,k is the output covariance of the one step ahead
prediction. ek = yˆk|k−1 − y¯k is the innovation. ny is the
number of data points. The model parameters estimate θˆ
is the minimizer of (10), i.e.
θˆ = argmin
θ
(L(θ)) (11)
Here, we compare the extended Kalman filter (EKF) with
the unscented Kalman filter (UKF) for the estimation
of ek and Re,k. The EKF has been designed for state
estimation of nonlinear systems. It is based on a first-order
linearization, see for instance Ljung (1979); Boiroux et al.
(2010a) for an implementation of the EKF.
The UKF has been developed by Julier et al. (1995, 2000).
It propagates the state and covariance estimates for a set
of wisely chosen points (also called sigma points) such
that the nonlinearities are more accurately propagated
than for the EKF. The UKF has been applied to plasma
insulin estimation based on glucose measurements, see
Eberle and Ament (2011). In many applications, the
UKF shows better performance than the EKF. Sarkka
(2007) presents a continuous-time and continuous-discrete
unscented Kalman filter (CDUKF).
Since only CGM glucose measurements are available, it
is quite likely that identifying all diffusion terms simul-
taneously will be difficult. In this paper, we applied the
following iterative procedure to determine which diffusion
terms can be identified, as shown in Kristensen et al.
(2004b); Duun-Henriksen et al. (2013)
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Fig. 3. Plasma and CGM glucose traces (top), and insulin
trace (bottom) for the considered virtual patient.
(1) Estimate the parameters of the deterministic version
of the model, i.e. set all the diffusion terms σi, i =
1, 2, ..., 7 to zero and only estimate the parameters re-
lated to the deterministic part in (2a)-(2h). Compute
the likelihood function value L0.
(2) Estimate the model (2a)-(2h) augmented with one
diffusion term. For each possible state (seven in total),
compute the statistic
D = 2(L− L0) (12)
where L is the likelihood of the augmented model, and
L0 is the initial likelihood. D follows a χ
2 distribution
with one degree of freedom.
(3) If a statistically significant improvement can be ob-
tained, i.e. if the p−value of (12) is below 0.05: take
the diffusion term that gave the lowest log-likelihood
value, and augment again the system with another
diffusion term to be estimated. Compute the new D
statistic for the augmented system compared to the
previous one.
(4) Iterate step 3 until no further improvement can be
obtained.
In our case, only the diffusion related to G(t) in (2d) can
be identified.
4. NUMERICAL RESULTS AND DISCUSSION
We use the parameters in Table 1 (second column) to
simulate a 24-hour scenario. The meals given in the consid-
ered scenario are: 70g CHO at 6AM, 70g CHO at 12PM
and 75g CHO at 6PM. A bolus of appropriate size has
been administered at mealtime for every meal. We assume
that the inputs (insulin infusion rate and meal size) are
perfectly known, and that the output is given by the CGM
measurements. For each state, we set σi = 0.01xss,i, where
xss,i is the steady state value for the i-th state in (2a)-(2h),
i = 1, 2, ..., 7. We use a random insulin administration
sequence uk = uss + ηk, where uss is the steady state
insulin administration and ηk ∼ N(0, 0.5uss), such that we
can identify the time constants of the model. We use the
Euler-Maruyama method Kloeden and Platen (1992) with
a constant stepsize to solve numerically the SDEs (2a)-
(2h). Fig. 3 shows the simulated plasma glucose, CGM
glucose and insulin traces for the considered patient.
4.1 Results
Using the algorithm presented in section 3.3 on the glucose
data reveals that only the diffusion term corresponding to
plasma glucose G(t) can be identified.
Table 1 shows the estimated parameter value and their
relative errors. It can be noticed that the errors can be
quite large, in particular for GEZI and EGP . It shows
that using data from a single patient makes the identifica-
tion of the MVP model quite difficult. The methods based
on maximum likelihood perform better at identifying the
parameters related to meal absorption (VG and τM ) as well
as the insulin sensitivity SI , which are the key parameters
for the design of a bolus calculator and the adjustment of
basal insulin.
Fig. 4 depicts the fits of each identification method for
the plasma glucose. Except for the weighted least squares
method, all the other methods show similar performance.
The unweighted least squares, Huber regression and max-
imum likelihood are able to capture the variations in glu-
cose level quite accurately. All the fittings show correlated
residuals since they approximate the SDE-GB model (2a)-
(2h) with a system of ODEs.
Table 2 illustrates the prediction results for the MVP
model. We investigated three prediction horizons: 1 step (5
minutes), 6 steps (30 minutes) and 12 steps (60 minutes).
The ability to make accurate prediction of the glucose
level is important in particular for model-based control
applications. We used the relative mean square error
(RMSE) to quantify the performance of the different
models. The RMSE is computed as
RMSE =
√∑N
k=1(y¯i − yˆi)2
N
(13)
in which yˆi is the estimated output from the model and
y¯i is the actual output value. Table 2 shows that the
unweighted least squares and the maximum likelihood
performs similarly. Interestingly, no improvement has been
noticed by using the unscented Kalman filter instead of the
extended Kalman filter for maximum likelihood estima-
tion. The weighted least squares performs the worst. The
Huber regression performs as well as the other methods
for short-term predictions, but its performance degrades
for long-term predictions (6- and 12-steps ahead).
4.2 Discussion
Unlike ODE models, SDE-GB model provide information
about the process noise distribution along with the param-
eter values. Therefore, it can be used to design a robust
predictive controller, as in Mahmood and Mhaskar (2012).
In addition, SDE-GB model identification can be used
for parameter tracking (Duun-Henriksen et al. (2013)). It
can identify intra-patient variability in physiology such as
changes in insulin sensitivity or changes in the postpran-
dial meal dynamics, for instance if the fat content differs.
Parameter tracking is a more systematic way to estimate
time-varying parameters or different meal absorption dy-
namics than defining different time windows. Automatic
parameter tracking is one of the major challenges in mod-
eling of glucose-insulin dynamics (Steil et al. (2010)).
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Table 1. Summary of the model identification results for the least squares (LS), weighted least
square (LS-W), maximum likelihood using an extended Kalman filter (ML-EKF) and maximum
likelihood using an unscented Kalman filter (ML-UKF), and their relative error (RE) compared
to the actual value.
Parameter Actual LS RE(%) LS-W RE(%) Huber RE(%) ML-EKF RE(%) ML-UKF RE(%)
τ1 (min) 49 65 31.8 71 44.2 62.8 21.9 69.0 40.8 71.2 45.3
τ2 (min) 47 65 37.5 71 50.5 60.7 22.6 69.0 46.8 70.9 50.8
CI (L/min) 2.01 2.6 27.3 3.1 52.3 3.5 43.2 2.7 32.7 2.6 29.5
p2 (10−2 min−1) 1.06 1.3 21.4 0.79 25.5 0.95 11.6 1.4 36.1 1.5 39.4
SI (10
−3 dL/mU) 8.11 9.8 20.5 13.0 60.1 14.5 44.0 9.2 12.9 9.4 15.9
GEZI (10−3 min−1) 2.2 10 360.7 5.8 165.3 3.2 32.2 11.2 435.5 12.3 458 1
EGP (mg/dL/min) 1.3 2.0 50.0 1.8 32.7 1.55 14.6 2.1 55.3 2.1 61.4
VG (dL) 253 228 10.1 376 48.5 309.2 18.2 239.9 5.2 226 10.5
τM (min) 47 45.3 3.6 68.9 46.5 43.7 7.5 44.6 5.4 45.7 2.8
σG - - - - - - - 2.4 - 2.84 -
Time [hh : mm]
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Fig. 4. Fits of the CGM data for the least squares (LS), weighted least square (LS-W), maximum likelihood using an
extended Kalman filter (ML-EKF) and maximum likelihood using an unscented Kalman filter (ML-UKF).
Another advantage of maximum likelihood modeling is
the possibility to refine the identification with data from
a large population. Population modeling and maximum
a posteriori estimation can improve the quality of the
PK/PD modeling Kristensen et al. (2004a); Jørgensen
and Jørgensen (2007a) and contribute to identify the
parameters of the MVP model more easily and accurately.
The main drawback of maximum likelihood estimation
remains the computation time needed to determine the
maximum of the log-likelihood function (10). This can
be overcome, as the model identification does not need
to be performed frequently (e.g. once a day or even less
frequently) and, if necessary, can be made remotely. Also,
efficient and robust implementation of the optimization
algorithm as well as faster mobile device can solve this
issue.
The Huber regression is an alternative if a lower compu-
tational cost is needed. It has the advantage of handling
outliers better than the classical least squares identifica-
tion without compromising the quality of the predictions.
However, the identification will have to be performed on
several time windows as in Kanderian et al. (2009) to
handle the intra-patient variability and the differences in
meal absorption dynamics.
Table 2. Model predictions Relative Mean
Square Error (RMSE, in mg/dL) for the five
different identification techniques.
ID 1-step 6-step 12-step
Tech RMSE RMSE RMSE
LS 9.8 12.9 13.7
LS-W 12.0 17.8 21.1
Huber 9.6 13.1 14.1
ML-EKF 9.9 12.9 13.6
ML-UKF 9.9 12.9 13.6
5. CONCLUSION
This paper compared different methods for model identi-
fication in people with T1D using CGM data for a single
patient with a possible application to NMPC. From the
numerical results and the subsequent discussion, we can
conclude that identification based on maximum likelihood
is the most suitable method for model identification in
people with T1D. It gives better results and offers more
flexibility, for instance for parameter tracking or to use
information from a large population. It also gives infor-
mation about the uncertainties that can be used in robust
control. Also, the use of a continuous-discrete unscented
Kalman filter does not bring any significant improvement
compared to the extended Kalman filter in that particular
case. Therefore, the use of an extended Kalman filter will
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reduce the computational cost compared to the unscented
Kalman filter for a similar performance. Further statistical
validation of the results will be conducted.
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